Hydroquinone for Pigmentation and Melasma: How to Use It Safely
Part of: Melasma & pigmentation
When hydroquinone helps pigmentation and melasma, how 2% and 4% differ, how long treatment lasts, the risks of prolonged use, and when to stop.
Pigmentation & melasma · 3 min read · October 7, 2026
Written and medically reviewed by Dr. Yousef Abo Zarad · German board-certified dermatologist · Last reviewed: October 2026
The short answer
Hydroquinone can fade melasma and brown marks left after acne.14 It does not treat every kind of discoloration, and it is not a general-purpose face-bleaching cream.
Use it for a defined treatment period on the affected areas, alongside daily sun protection and a review with your dermatologist.26
Which pigmentation can it treat?
It can help melasma and brown post-acne marks when the diagnosis is clear.14
- Melasma: pigmentation may fade, but it can return when triggers such as sun exposure persist.24
- Post-acne marks: it can fade lingering brown marks while the underlying acne also needs treatment.1
- Under-eye darkness: if vessels, hollowing, or shadows cause the darkness, hydroquinone cannot correct those causes.
Have a new unusual spot, changing mole or bleeding lesion examined before putting a lightening cream on it.
2% or 4%?
For active melasma, hydroquinone 4% is among the best-studied strengths.4
Hydroquinone 2% may be used during maintenance after the pigmentation has improved.9 This is not a rule for everyone; the right treatment depends on severity and skin tolerance.
When will results appear?
Review the response after 6–8 weeks; improvement takes weeks, not days.9
Improvement with 4% hydroquinone was observed over 60 days, though individual responses vary.3
How long can I use it?
Hydroquinone alone: for melasma, a typical course is about 3 months, with the response reviewed after 6–8 weeks.49 The dermatologist then decides whether to adjust, extend or stop treatment.
Triple-combination cream (4% hydroquinone with tretinoin and fluocinolone): typically used for up to 8 weeks and stopped once melasma is controlled.46 It is not intended for indefinite daily maintenance.
What is blue-grey discoloration (ochronosis)?
Exogenous ochronosis is an uncommon blue-grey or blue-black discoloration that has been associated with prolonged hydroquinone use.5
Among published cases, the median duration of exposure was about five years. That is neither a safe-use threshold nor an estimate of how often the condition occurs.5
Can I apply it to my entire face?
No. Hydroquinone is not meant for general face bleaching. It is applied to diagnosed areas of pigmentation; these may be broad in melasma or more localized with post-acne marks.
Do not apply it to broken or irritated skin to speed results. Burning or inflammation can worsen dark marks rather than help them.6
Can I combine it with tretinoin?
Yes. A prescription triple combination containing hydroquinone and tretinoin treats moderate-to-severe facial melasma for a limited period. It should not be assembled by mixing creams at home.6
- Hydroquinone: 4%.
- Tretinoin: 0.05%.
- Fluocinolone: 0.01% to reduce inflammation. These are the concentrations in the established triple-combination product.6
Is hydroquinone safe during pregnancy?
Avoid hydroquinone during pregnancy. Pregnancy safety data are limited, and some of the applied medicine is absorbed through the skin. Cosmetic pigment treatment can usually wait.78
This is a precaution based on limited safety information, not evidence that exposure inevitably causes birth defects.8
Do I need sunscreen with it?
Yes. Without daily sun protection, melasma may remain difficult to control and can return after improvement.2
Choose broad-spectrum SPF 30 or higher. For melasma, tinted sunscreen with iron oxides also helps protect against visible light.2
When should you stop?
Stop hydroquinone and contact your dermatologist if the skin develops an unusual color, serious irritation, or no improvement after the agreed review period.56
Medical Evidence
- Global consensus on the management of melanin hyperpigmentation disorders (Passeron et al., 2026)
- Melasma: Diagnosis and treatment
- Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double-blind, controlled clinical trial (de Amorim et al., 2024)
- Topical and Systemic Therapies in Melasma: A Systematic Review
- Exogenous ochronosis associated with hydroquinone: a systematic review (Ishack & Lipner, 2022)
- TRI-LUMA (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) — official drug label
- Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition (Wester et al., 1998)
- Safety of skin care products during pregnancy (Bozzo et al., 2011)
- Latin American consensus on the treatment of melasma (Ocampo-Candiani et al., 2025)